Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 9 of 124)
- Relevance
  Sort by

Colorectal Cancer Therapeutics Market 2024-2028

 Report
June 2024
146 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Ependymoma Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
94 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End-use, By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
110 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028

 Report
February 2022
360 Pages
United States

From

€3576EUR$3,600USD£2,974GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
532 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Lupus Nephritis Treatment Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€5463EUR$5,499USD£4,542GBP

Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028

 Report
February 2020
160 Pages
Global

From

€10923EUR$10,995USD£9,082GBP

Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027

 Report
July 2023
223 Pages
Global

From

€3800EUR$3,825USD£3,159GBP

€4471EUR$4,500USD£3,717GBP

Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology And Market Forecast - 2034

 Report
August 2024
265 Pages
Global

From

€5529EUR$5,565USD£4,597GBP

€7898EUR$7,950USD£6,567GBP

HPV Associated Disorders Market by Indication, Therapy, Distribution - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Pediatric Drugs and Vaccines - Global Strategic Business Report

 Report
November 2024
292 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Antibacterial Drugs - Global Strategic Business Report

 Report
November 2024
244 Pages
Global

From

€5414EUR$5,450USD£4,502GBP

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
2271 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Bladder Cancer Therapeutics and Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

 Report
October 2023
174 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Melanoma Therapeutics Market Size, Share & Trends Analysis Report By Product (Chemotherapy, Immunotherapy), By Drug Type (Branded Drugs, Generic Drugs), By Region, And Segment Forecasts, 2023 - 2030

 Report
September 2023
100 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1036 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
143 Pages
Global

From

€1987EUR$2,000USD£1,652GBP

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024

 Report
September 2024
450 Pages
Global

From

€3969EUR$3,995USD£3,300GBP

2,463 Results (Page 9 of 124)
- 1
- 7
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.